An anti-amyloid antibody drug that reduces amyloid beta proteins in the brain has provided a novel treatment for Alzheimer s disease. This innovative brain imaging solution for Alzheimer s disease management can analyze Amyloid-Related Imaging Abnormalities (ARIA), a known side-effect in patients using the anti-amyloid drug. Previously, careful monitoring and management of ARIA was crucial due to the drug s side effects.

An Artificial Intelligence (AI) company, Neurophet, specializes in brain diseases. Neurophet has created a new technology that examines ARIA-E (edema), generally detected by T2-FLAIR, and MRI sequence, along with ARIA-H (hemorrhages), mostly recognized by GRE or SWI. To properly observe cortical amyloid beta deposition, an amyloid-PET scan is essential. The AI technology developed by Neurophet predicts amyloid positivity through Magnetic Resonance (MR) images before conducting amyloid-PET scans. Since amyloid-PET scans are expensive and their use and recompense are severely restricted, the use of MR images for predicting amyloid positivity could offer a cost-effective solution in regards to clinical trials and prognosis of Alzheimer s.

Neurophet set the stage at the 2023 Alzheimer s Association International Conference (AAIC) with its cutting-edge brain imaging analysis technology, which can be used in both clinical trials and Alzheimer s disease drug prescriptions.

AQUA software, a brain MRI analysis tool, examines brain atrophy observed in neurodegenerative diseases such as Alzheimer s by measuring cortical amyloid beta deposition, a known causative agent of the disease. Neurophet hopes to bring the products to market side-by-side with new Alzheimer s disease treatments. The company has invested in research and development focused on ARIA side effects.

RadParts, a TTG Imaging Solutions Company, is the world s largest independent distributor of OEM replacement parts. We specialize in low-cost parts for repairing linear accelerators and radiation equipment. Our mission is to provide high-quality, user-friendly, low-cost components and support for linear accelerators and radiation equipment. Contact RadParts at 877-704-3838 to learn more.

Written by the digital marketing team at Creative Programs & Systems: https://www.cpsmi.com/

• Understanding Linear Accelerators and Their Role in Cancer Treatment
• Israeli Child Receives Pioneering Seated Proton Therapy with Innovative System
• Significant Milestone Reached in Compact Particle Accelerator Technology
• Innovative Radiotherapy Method Potentially Halves Treatment Duration for Head and Neck Cancer
• WSU Veterinary Hospital Installs a New Linear Accelerator to Fight Cancer
• Patients Privately Pay $2,500 for a Full-Body MRI Scan to Detect Cancer
• MIT and Dana-Farber's Breakthrough in Identifying Cancer Origins
• Available Diagnostic Imaging for Smaller Communities & Young Athletes
• New MR, PET Images Analyze Alzheimer’s Biomarkers
• Prostate Cancer Treatment Vastly Improved